HomeCompareBAX vs CVX

BAX vs CVX: Dividend Comparison 2026

BAX yields 2.28% · CVX yields 3.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVX wins by $28.6K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
CVX
Chevron Corporation
● Live price
3.28%
Share price
$210.76
Annual div
$6.91
5Y div CAGR
24.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.2K
Annual income
$4,937.38
Full CVX calculator →

Portfolio growth — BAX vs CVX

📍 CVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXCVX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + CVX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
CVX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
CVX
Annual income on $10K today (after 15% tax)
$278.68/yr
After 10yr DRIP, annual income (after tax)
$4,196.77/yr
At 15% tax rate, CVX beats the other by $4,188.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + CVX for your $10,000?

BAX: 50%CVX: 50%
100% CVX50/50100% BAX
Portfolio after 10yr
$34.9K
Annual income
$2,473.82/yr
Blended yield
7.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CVX right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
CVX
Analyst Ratings
32
Buy
16
Hold
4
Sell
Consensus: Buy
Price Target
$184.54
-12.4% upside vs current
Range: $160.00 — $212.00
Altman Z
3.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
CVX buys
0
No recent congressional trades found for BAX or CVX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXCVX
Forward yield2.28%3.28%
Annual dividend / share$0.36$6.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%24.1%
Portfolio after 10y$20.6K$49.2K
Annual income after 10y$10.26$4,937.38
Total dividends collected$602.00$18.4K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$19.75$184.54

Year-by-year: BAX vs CVX ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrCVX PortfolioCVX Income/yrGap
1← crossover$10,866$166.33$11,387$406.88$521.00CVX
2$11,750$123.31$13,026$523.64$1.3KCVX
3$12,664$90.97$14,980$677.06$2.3KCVX
4$13,617$66.89$17,328$880.00$3.7KCVX
5$14,619$49.07$20,177$1,150.51$5.6KCVX
6$15,679$35.94$23,668$1,514.12$8.0KCVX
7$16,802$26.30$27,995$2,007.45$11.2KCVX
8$17,998$19.23$33,422$2,683.68$15.4KCVX
9$19,272$14.05$40,319$3,621.22$21.0KCVX
10$20,631$10.26$49,208$4,937.38$28.6KCVX

BAX vs CVX: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

CVXEnergy

Chevron Corporation, through its subsidiaries, engages in integrated energy and chemicals operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant. The Downstream segment engages in refining crude oil into petroleum products; marketing crude oil, refined products, and lubricants; manufacturing and marketing of renewable fuels; transporting crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car; and manufacturing and marketing of commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives. It is also involved in the cash management and debt financing activities; insurance operations; real estate activities; and technology businesses. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is based in San Ramon, California.

Full CVX Calculator →
📬

Get this BAX vs CVX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAINBAX vs XOMBAX vs COPBAX vs OXY

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.